Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR)

Fig. 1

Inverse probability of treatment weighting score adjusted survival curves from Cox-proportional hazards models for death or myocardial infarction (MI) according to discharge treatment in overall and various subgroups. a Non-STEMI population, b STEMI population, c hypertension history population, d diabetes mellitus population, e kidney disease population, f non-kidney disease population. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; STEMI, ST segment elevation myocardial infarction; RASI, renin angiotensin system inhibitor; eGFR-MDRD, estimates glomerular filtration rate-the original modification of diet in renal disease

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us